GSK, Google parent forge £540m bioelectronic medicines firm

London

GLAXOSMITHKLINE (GSK) and Google parent Alphabet's life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a novel field of medicine called bioelectronics.The tie-up shows the growing convergence of health care and technology.

Verily Life Sciences - known as Google's life sciences unit until last year - and Britain's biggest drugmaker will together contribute £540 million (S$953.9 million) over seven years to Galvani Bioelectronics, they said on Monday.